Stevanato group and gerresheimer ag announce collaboration on the development of an innovative ready-to-use vial platform for the pharmaceutical industry

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, and gerresheimer ag, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics, announce that they have jointly developed a high-end ready-to-use (rtu) solution platform with an initial focus on vials, based on stevanato gr
STVN Ratings Summary
STVN Quant Ranking